The clear telehealth consultations, lab test options, and medication instructions help first-time users feel confident and safe
Cardiovascular benefits The SELECT trial a landmark cardiovascular outcomes study involving over 17,000 participants showed that semaglutide reduced the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) by 20% in people with obesity who did not have diabetes
These discrepancies highlight the need for further investigation
6 Alternatively, some patients may be prescribed sulfonylureas or thiazolidiniones to improve insulin secretion, but both of these treatment options are associated with an elevated risk of heart failure making them unsuitable for use in patients with cardiovascular disease
Below, you'll see a comparison table of Brello Health vs popular GLP-1 providers :
Unlike previous GLP-1s that worked on one or two hormone receptors, Retarditude works on three